JMP Securities analyst, Michael King, reiterated his Market Outperform rating on shares of NovoCure Ltd. (NASDAQ: NVCR) after the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE